Complementary Technologies Maximize Analytical Capabilities, Enable
Researchers to Advance Discovery in Cancer, Other Complex Diseases
Glycomics is the study of glycome structures (sugars, modified sugars and saccharides) in molecules and organisms, a tangled web of carbohydrates, proteins and lipids that modulate cellular function and play a primary role in the development of cancer, bacterial and viral diseases, and glycan-specific hereditary diseases. These structures are very difficult to study due to their complexity and kinetics.
“Agilent and PREMIER Biosoft are focused on solving the glycan and glycopeptide identification problem in biopharmaceutical analyses,” said PREMIER Biosoft CEO
“Used together, our powerful instrumentation and software fulfills a major unmet need for customers in biopharmaceutical research and development laboratories,” said
For more information on Agilent’s LC/MS solutions, please click here.
Information on SimGlycan software is available athttp://premierbiosoft.com/glycan/index.html.
About PREMIER Biosoft
PREMIER Biosoft (www.premierbiosoft.com) was founded in 1994. The company is led by computer scientists, statisticians and biologists dedicated to producing cutting-edge intuitive software for research in life sciences. The company’s goal is to study the most recent innovations in life sciences and translate them into software products to aid research. Follow PREMIER Biosoft on Twitter @PREMIERBiosoft and on Facebook.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is available at www.agilent.com/go/news.